目的 :分析并对幽门螺杆菌(Hp)阳性胃病患者的临床方法,观察疗效。方法 :选择88例Hp阳性胃病患者,平均分为对照组与观察组,对照组采取传统的三联疗法进行治疗,观察组应用穿王消炎胶囊同阿莫西林克拉维酸钾胶囊相联合的治疗方式,疗程均为2周,对两组患者临床的治疗效果与安全性进行观察并对比。结果 :经过治疗,对照组临床治疗的总有效率为81.82%,明显低于观察组的90.91%(P<0.05)。结论 :应用过程中的治疗方法能够获得显著的临床应用效果,值得推广并应用。 Objective: To analyze and evaluate the clinical efficacy of Helicobacter pylori (Hp) -positive gastric patients. Methods: Eighty-eight patients with Hp-positive stomach were selected and divided into control group and observation group. The control group was treated with traditional triple therapy. The observation group was treated with combination of Wangwangyinyan capsule and amoxicillin-clavulanate potassium capsule , The course of treatment was 2 weeks, the clinical efficacy and safety of the two groups of patients were observed and compared. Results: After treatment, the total effective rate of clinical treatment in the control group was 81.82%, which was significantly lower than that in the observation group (90.91%, P <0.05). Conclusion: The application of the treatment method can get significant clinical effect, it is worth promoting and application.